Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Mostrar otras versiones (1)

Effective therapeutics to treat COVID-19 are urgently needed. While many investigational, approved, and repurposed drugs have been suggested, preclinical data from animal models can guide the search for effective treatments by ruling out treatments without in vivo efficacy. Remdesivir (GS-5734) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Brandi N., Feldmann, Friederike, Schwarz, Benjamin, Meade-White, Kimberly, Porter, Danielle P., Schulz, Jonathan, van Doremalen, Neeltje, Leighton, Ian, Yinda, Claude Kwe, Pérez-Pérez, Lizzette, Okumura, Atsushi, Lovaglio, Jamie, Hanley, Patrick W., Saturday, Greg, Bosio, Catharine M., Anzick, Sarah, Barbian, Kent, Cihlar, Tomas, Martens, Craig, Scott, Dana P., Munster, Vincent J., de Wit, Emmie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486271/
https://www.ncbi.nlm.nih.gov/pubmed/32516797
http://dx.doi.org/10.1038/s41586-020-2423-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486271/
https://www.ncbi.nlm.nih.gov/pubmed/32516797
http://dx.doi.org/10.1038/s41586-020-2423-5

Ejemplares similares